{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:58:32Z","timestamp":1773305912594,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.virol.2018.03.005","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T20:57:19Z","timestamp":1521406639000},"page":"284-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Characterization of murine antibody responses to vaccinia virus envelope protein A14 reveals an immunodominant antigen lacking of effective neutralization targets"],"prefix":"10.1016","volume":"518","author":[{"given":"Xiangzhi","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kaever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Traktman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk M.","family":"Zajonc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjoern","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane","family":"Crotty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2018.03.005_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virol.2005.07.006","article-title":"Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene","volume":"341","author":"Aldaz-Carroll","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.03.005_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2004.05.004","article-title":"Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin","volume":"325","author":"Bell","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.03.005_bib3","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"Belyakov","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.virol.2018.03.005_bib4","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/JVI.01797-08","article-title":"Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement","volume":"83","author":"Benhnia","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.005_bib5","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1128\/JVI.02244-07","article-title":"Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine","volume":"82","author":"Benhnia","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.005_bib6","doi-asserted-by":"crossref","first-page":"W503","DOI":"10.1093\/nar\/gkn316","article-title":"IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis","volume":"36","author":"Brochet","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2018.03.005_bib7","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1128\/JVI.80.5.2127-2140.2006","article-title":"Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles","volume":"80","author":"Chung","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.005_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0065-3527(06)66002-8","article-title":"In a nutshell: structure and assembly of the vaccinia virion","volume":"66","author":"Condit","year":"2006","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.virol.2018.03.005_bib9","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","article-title":"Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice","volume":"79","author":"Davies","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.005_bib10","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/pmic.200600926","article-title":"Proteome-wide analysis of the serological response to vaccinia and smallpox","volume":"7","author":"Davies","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.virol.2018.03.005_bib11","series-title":"Current Protocols in Molecular Biology","article-title":"Generation of recombinant vaccinia viruses","author":"Earl","year":"1998"},{"key":"10.1016\/j.virol.2018.03.005_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.vetmic.2009.08.026","article-title":"Zoonotic poxviruses","volume":"140","author":"Essbauer","year":"2010","journal-title":"Vet. Microbiol"},{"key":"10.1016\/j.virol.2018.03.005_bib13","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1086\/520936","article-title":"Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity","volume":"196","author":"He","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2018.03.005_bib14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1086\/422999","article-title":"Clinical efficacy of intramuscular vaccinia immune globulin: a literature review","volume":"39","author":"Hopkins","year":"2004","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.virol.2018.03.005_bib15","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1128\/JVI.73.10.8750-8761.1999","article-title":"Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells","volume":"73","author":"Hsiao","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.005_bib16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/viro.1996.0337","article-title":"Neutralizing epitope on penetration protein of vaccinia virus","volume":"220","author":"Ichihashi","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.03.005_bib17","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1128\/JVI.02878-15","article-title":"Linear epitopes in vaccinia virus A27 are targets of protective antibodies induced by vaccination against smallpox","volume":"90","author":"Kaever","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.005_bib18","doi-asserted-by":"crossref","first-page":"11339","DOI":"10.1128\/JVI.01491-14","article-title":"Potent neutralization of vaccinia virus by divergent murine antibodies targeting a common site of vulnerability in l1 protein","volume":"88","author":"Kaever","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.005_bib19","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","article-title":"Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge","volume":"79","author":"Lustig","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.005_bib20","doi-asserted-by":"crossref","first-page":"12313","DOI":"10.1128\/JVI.02137-13","article-title":"Direct formation of vaccinia virus membranes from the endoplasmic reticulum in the absence of the newly characterized L2-interacting protein A30.5","volume":"87","author":"Maruri-Avidal","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.005_bib21","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3851\/IMP1573","article-title":"Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model","volume":"15","author":"McCausland","year":"2010","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.virol.2018.03.005_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3201\/eid1801.110692","article-title":"Vaccinia virus zoonotic infection Sao Paulo state Brazil","volume":"18","author":"Megid","year":"2012","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2018.03.005_bib23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.virol.2010.10.019","article-title":"Generation and characterization of a large panel of murine monoclonal antibodies against vaccinia virus","volume":"409","author":"Meng","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.03.005_bib24","doi-asserted-by":"crossref","first-page":"8857","DOI":"10.1128\/JVI.77.16.8857-8871.2003","article-title":"Investigation of structural and functional motifs within the vaccinia virus A14 phosphoprotein an essential component of the virion membrane","volume":"77","author":"Mercer","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.005_bib25","series-title":"Fields Virology.","first-page":"2905","article-title":"Poxviridae: The viruses and their replication","author":"Moss","year":"2007"},{"key":"10.1016\/j.virol.2018.03.005_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/17460913.2.1.17","article-title":"Human monkeypox: an emerging zoonotic disease","volume":"2","author":"Parker","year":"2007","journal-title":"Future Microbiol."},{"key":"10.1016\/j.virol.2018.03.005_bib27","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm1457","article-title":"Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination","volume":"12","author":"Putz","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2018.03.005_bib28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMoa032299","article-title":"The detection of monkeypox in humans in the Western Hemisphere","volume":"350","author":"Reed","year":"2004","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.virol.2018.03.005_bib29","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1128\/jvi.56.2.482-488.1985","article-title":"Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus","volume":"56","author":"Rodriguez","year":"1985","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.005_bib30","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1128\/JVI.72.2.1287-1296.1998","article-title":"Vaccinia virus 15-kilodalton (A14L) protein is essential for assembly and attachment of viral crescents to virosomes","volume":"72","author":"Rodriguez","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.005_bib31","doi-asserted-by":"crossref","first-page":"7404","DOI":"10.1128\/jvi.71.10.7404-7420.1997","article-title":"Vaccinia virus membrane proteins p8 and p16 are cotranslationally inserted into the rough endoplasmic reticulum and retained in the intermediate compartment","volume":"71","author":"Salmons","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.005_bib32","doi-asserted-by":"crossref","first-page":"e1003756","DOI":"10.1371\/journal.ppat.1003756","article-title":"An increasing danger of zoonotic orthopoxvirus infections","volume":"9","author":"Shchelkunov","year":"2013","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.virol.2018.03.005_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13337-012-0068-1","article-title":"Emergence and reemergence of vaccinia-like viruses: global scenario and perspectives","volume":"23","author":"Singh","year":"2012","journal-title":"Indian J. Virol."},{"key":"10.1016\/j.virol.2018.03.005_bib34","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2018.03.005_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jim.2009.08.009","article-title":"Cloning and expression of murine Ig genes from single B cells","volume":"350","author":"Tiller","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.virol.2018.03.005_bib36","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3201\/eid1307.061404","article-title":"Brazilian vaccinia viruses and their origins","volume":"13","author":"Trindade","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2018.03.005_bib37","doi-asserted-by":"crossref","first-page":"E11001","DOI":"10.1073\/pnas.1716255114","article-title":"Enigmatic origin of the poxvirus membrane from the endoplasmic reticulum shown by 3D imaging of vaccinia virus assembly mutants","volume":"114","author":"Weisberg","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2018.03.005_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies","volume":"211","author":"Wolffe","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.03.005_bib39","doi-asserted-by":"crossref","first-page":"11276","DOI":"10.1128\/JVI.01502-12","article-title":"Vaccinia virus virion membrane biogenesis protein A11 associates with viral membranes in a manner that requires the expression of another membrane biogenesis protein, A6","volume":"86","author":"Wu","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.03.005_bib40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virol.2011.06.029","article-title":"An epitope conserved in orthopoxvirus A13 envelope protein is the target of neutralizing and protective antibodies","volume":"418","author":"Xu","year":"2011","journal-title":"Virology"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682218300837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682218300837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:48:48Z","timestamp":1758588528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682218300837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":40,"alternative-id":["S0042682218300837"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2018.03.005","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of murine antibody responses to vaccinia virus envelope protein A14 reveals an immunodominant antigen lacking of effective neutralization targets","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2018.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}